Evidence map›Paper›PMID 40248613›Full record

ArticleAdvances in oncology2024

Diagnostic and theranostic opportunities in Neuro-oncology.

Zsombor Ritter, Georg Oeltzschner, Lilja Bjork Solnes, Guanshu Liu, David Olayinka Kamson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Clinical profile and outcomes of pediatric ependymoma: a 10-year retrospective analysis from a resource-limited setting.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zsombor RitterThe Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital, Baltimore, MD.
Georg OeltzschnerRussell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, MD.
Lilja Bjork SolnesRussell H. Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine and Molecular Imaging, Johns Hopkins University School of Medicine, Baltimore, MD.
Guanshu LiuRussell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, MD.
David Olayinka KamsonThe Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital, Baltimore, MD.

Funding

Multimodal MRI for guiding bacterial cancer therapyR01CA261974 · NCI · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI Renyuan Bai, Guanshu Liu · 2022 to 2026
$1.8M
NCI NIH HHS R01 CA261974
6 · The paper itself

Abstract

Theranostics, the interlinking of diagnostic and therapeutic procedures, can be particularly valuable in neuro-oncology, addressing the challenges posed by the blood-brain and brain-tumor barriers. While it is traditionally associated with nuclear medicine, advances in MR imaging techniques have opened new theranostic frontiers. This review covers the present challenges in neuro-oncology and how these could be overcome utilizing radioligand-based molecular radiotherapy as well as how label-free theranostics employing methods such as chemical exchange saturation transfer (CEST) and MR spectroscopy could advance the field.

Indexed as

brain metastasesglioblastomaMRIneuro-oncologyPETradioligand therapyTheranosticstherapeutic delivery

Identifiers

PMID40248613
PMCPMC12001827

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.